ShadowBuys
Sign inJoin for free

Rep. Josh Gottheimer sold Regeneron Pharmaceuticals (REGN)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Nov 29, 2024

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
Joint
Traded
Nov 29, 2024
Disclosed
Dec 5, 2024
Days to disclose
6
Asset type
Stock
As filed
Regeneron Pharmaceuticals, Inc. - Common Stock
Industry
Biotechnology · Healthcare
Official filing ↗All of Gottheimer's tradesAll Congress trades in REGN

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in REGN

Company context for REGN

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. REGNFinancial report·SEC EDGAR

    REGN: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 30, 2026, 6:55 AM EDTEvent / period: Sep 30, 2026Original source ↗
  2. REGNCompany announcement·SEC EDGAR

    REGN: Financial results

    Filed 8-K for an event or period dated 2026-10-30. Financial results.

    Public: Oct 30, 2026, 6:50 AM EDTEvent / period: Oct 30, 2026Original source ↗
  3. REGNCompany announcement·SEC EDGAR

    REGN: Material agreement · Financial results · Other company developments

    Filed 8-K for an event or period dated 2026-10-01. Material agreement; Financial results; Other company developments.

    Public: Oct 6, 2026, 7:51 AM EDTEvent / period: Oct 1, 2026Original source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.